Anavex 3-71 will most probably be proven to be safe and efficacious at all doses tested for all cohorts tested during the Phase 2 schizophrenia trial. That will result in FDA approval for Anavex 3-71.
Thanks for clarifying misinformation published to lead misinformed investors into thinking this is practically a ‘done deal’ with the FDA , when even phase 3 is months away. Some will swallow though as they have in the past.